Cargando…
Identification and validation of a novel overall survival prediction model for immune-related genes in bone metastases of prostate cancer
Immunotherapy has become a revolutionary treatment for cancer and brought new vitality to tumor immunity. Bone metastases are the most prevalent metastatic site for advanced prostate cancer (PCa). Therefore, finding new immunotherapy targets in PCa patients with bone metastasis is urgently needed. W...
Autores principales: | Bi, Wen, Guo, Weiming, Fan, Gang, Xie, Lei, Jiang, Changqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415549/ https://www.ncbi.nlm.nih.gov/pubmed/37494663 http://dx.doi.org/10.18632/aging.204900 |
Ejemplares similares
-
Radiotherapy cannot prolong overall survival of young prostate cancer patients with bone metastases
por: Peng, Bo, et al.
Publicado: (2016) -
Development and validation of two nomograms for predicting overall survival and Cancer-specific survival in prostate cancer patients with bone metastases: a population-based study
por: Li, Baochao, et al.
Publicado: (2023) -
Overall survival nomogram for patients with spinal bone metastases (SBM)
por: Osong, Biche, et al.
Publicado: (2021) -
A Novel Overall Survival Prediction Signature Based on Comprehensive Research in Prostate Cancer Bone Metastases
por: Hu, Konghe, et al.
Publicado: (2022) -
Identification and validation of a hypoxia-immune signature for overall survival prediction in lung adenocarcinoma
por: Li, Yong, et al.
Publicado: (2022)